AHA Coding Clinic® for HCPCS - 2012 Issue 3; For Your Information

New HCPCS Codes for Certain Drugs and Biologicals

CMS has created five new HCPCS codes for the reporting of certain drugs and biologicals (other than new pass-through drugs and biologicals). These codes became effective July 1, 2012 and are listed in the next column. HCPCS CodeLong DescriptorQ2045* Injection, human, fibrinogen concentrate, 1 mg Q2046** Injection, aflibercept, 1mg Q2048*** Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg Q2049 Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg Q2034 Influenza virus vaccine, split virus, for intramuscular use (Agriflu) *Effective since July 1, 2012, Level II HCPCS code J1680, Injection, human fibrinogen concentrate, 100 mg, was replaced with HCPCS code Q2045. **Effective...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.